Search for: "Teva Pharmaceuticals"
Results 1181 - 1200
of 1,430
Sorted by Relevance
|
Sort by Date
30 May 2012, 8:28 am
Teva Pharmaceuticals USA, Inc., 2012 U.S. [read post]
25 Jan 2011, 10:58 pm
Cephalon (Patently-O) Seroquel (Quetiapine) – UK: Teva launches High Court action to revoke AstraZeneca’s European patent (IP Factor) Synagis – US: PDL BioPharma Synagis patent invalidated: Medimmune v PDL BioPharma (Patent Docs) Tarka (Trandolapril, Verapamil) – US: Glenmark loses jury verdict in DNJ over Tarka (IPBiz) Wechol (Colesevelam) – US: Watson confirms Welchol oral suspension patent challenge (SmartBrief) [read post]
26 Oct 2011, 2:30 am
– opinion on valuable patent life of a pharmaceutical product (The SPC Blog) EU: CJEU rules no patent protection for human embryonic stem cell-related inventions: Brüstle v Greenpeace (IPEG) (ipwars.com) (EPLAW) (IPBiz) (Patent Baristas) EU: CJEU says no to patents requiring the destruction of a human embryo – Brüstle v Greenpeace – an Australian perspective (IP Whiteboard) EU: Stem cell patent decision hurts science – Brüstle v Greenpeace (BIOtechNOW)… [read post]
7 Sep 2011, 4:22 am
: Pfizer v Teva (Property, intangible) [read post]
26 Mar 2012, 1:43 am
Circuit’s 2010 decision in Teva Pharmaceuticals USA, Inc. v. [read post]
12 Jun 2014, 10:41 am
Teva Pharmaceuticals USA, Inc. [read post]
27 Oct 2010, 12:17 pm
Yohn Jr. in Teva v. [read post]
7 Jun 2011, 10:12 am
Teva Pharmaceuticals USA, Inc., 10-1070 (second relist since the Court called for a response). [read post]
14 Mar 2014, 8:00 am
First up is Teva Pharmaceuticals USA, Inc. v. [read post]
2 Nov 2011, 2:00 am
Teva Pharmaceuticals USA et al (Docket Report) US: Fred Hutchinson Cancer Research Center files patent infringement complaint against Branhaven over sales of Canine Heritage XL Breed Test (Patent Docs) Products Atelvia (Risedronate sodium delayed-release) – US: Warner Chilcott files patent infringement complaint against Watson in response to Para IV certification (Patent Docs) Butrans (Buprenorphine) – US: PTO says PTE not available in “reverse… [read post]
2 Nov 2010, 10:26 am
Teva Pharmaceuticals, 395 F.3d 1364, 1370, 1379 (Fed. [read post]
29 Apr 2020, 6:53 am
Pricing mechanisms in the pharmaceuticals sector are strongly controlled by legislation. [read post]
5 Jul 2013, 5:00 am
Teva Parental Medicines, Inc., 795 F. [read post]
15 Aug 2010, 6:29 pm
Harvard Management Company stated in its 13-F Form that it sold 483,590 shares in Teva Pharmaceutical Industries Ltd. [read post]
14 Dec 2010, 7:06 pm
Keith Webber, Deputy Director of the Office of Pharmaceutical Science (and acting OGD Director) determined that the five criteria are a “valid approach . . . for purposes of ANDA approval. [read post]
1 Nov 2012, 2:37 pm
For those up the line they may, as with the Teva cases we discussed earlier this year, allege negligent and/or defective packaging - i.e. failure to break the doses into the smallest possible units so as to effectively eliminate multiuse and, in large part, compounding, altogether. [read post]
1 May 2014, 4:59 am
The same is true with regard to Teva’s ability to alter Gianvi’s design or composition. [read post]
10 Sep 2018, 10:17 am
.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
20 Jul 2011, 4:04 am
– Economic Times reports ‘Letter of Understanding’ between EU and India (Spicy IP) (Generic Pharmaceuticals and IP) France considers paralysing IP rights on the appearance of generic drugs (Class 46) India: Application of Orphan Drug Act to section 3(d)? [read post]
27 Jun 2011, 8:41 am
” Certiorari stage documents: Opinion below (3d Circuit) Petition for certiorari Brief in opposition Petitioners’ supplemental brief Respondents’ supplemental brief Petitioners’ reply Amicus brief of TEVA Pharmaceuticals USA, Inc. [read post]
